Vive Organic Closes $13-Million Series B Funding Round Led by Monogram Capital

Vive Organic, makers of doctor crafted, cold-pressed wellness shots, announces today the closing of a $13-million Series B funding round led by Monogram Capital with participation by Cambridge SPG and Powerplant Ventures. Vive is one of the leading functional beverage brands in the market today, providing customers with cold-pressed wellness shots that are formulated with a focus on boosting the immune system. The brand has seen explosive growth since inception in 2015, with an average of 400% growth year over year, and has cemented itself as the leader in this space. This backing from industry veterans further validates the growth opportunity within this category and consumer demand more broadly for immunity-boosting products